Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndrome

BMC Immunology

Volumn 13, Issue , 2012, Pages

  Prinsen, Hetty ^a   de Vries, I Jolanda M ^a   Torensma, Ruurd ^a   Pots, Jeanette M ^a   Mulder, Sasja F ^a   van Herpen, Carla M L ^a   Elving, Lammy D ^a   Bleijenberg, Gijs ^a   Stelma, Foekje F ^a   van Laarhoven, Hanneke W M ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cellular immunity; Chronic fatigue syndrome; Humoral immunity; Influenza; Vaccination

Indexed keywords

ANTIBODY; CYTOKINE; INFLUENZA VACCINE;

ADULT; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOREACTIVITY; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; LYMPHOCYTE PROLIFERATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; REGULATORY T LYMPHOCYTE; SEROLOGY; T LYMPHOCYTE; VIRUS STRAIN;

ADULT; ANTIBODY FORMATION; CASE-CONTROL STUDIES; FATIGUE SYNDROME, CHRONIC; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INFLUENZA VACCINES; MALE; MIDDLE AGED; VACCINATION;

EID: 84871002980     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-13-71     Document Type: Article

References (32)

1. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A, . International Chronic Fatigue Syndrome Study Group The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994, 121(12):953-959. International Chronic Fatigue Syndrome Study Group.
2. Lorusso L, Mikhaylova SV, Capelli E, Ferrari D, Ngonga GK, Ricevuti G. Immunological aspects of chronic fatigue syndrome. Autoimmun Rev 2009, 8(4):287-291. 10.1016/j.autrev.2008.08.003, 18801465.
3. Castell BD, Kazantzis N, Moss-Morris RE. Cognitive behavioral therapy and graded exercise for chronic fatigue syndrome: a meta-analysis. Clin Psychol: Sci Pract 2011, 18(4):311-324.
4. Chambers D, Bagnall AM, Hempel S, Forbes C. Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review. J R Soc Med 2006, 99(10):506-520. 10.1258/jrsm.99.10.506, 1592057, 17021301.
5. Malouff JM, Thorsteinsson EB, Rooke SE, Bhullar N, Schutte NS. Efficacy of cognitive behavioral therapy for chronic fatigue syndrome: a meta-analysis. Clin Psychol Rev 2008, 28(5):736-745. 10.1016/j.cpr.2007.10.004, 18060672.
6. Nijhof SL, Bleijenberg G, Uiterwaal CS, Kimpen JL, van de Putte EM. Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial. Lancet 2012, 379(9824):1412-1418. 10.1016/S0140-6736(12)60025-7, 22385683.
7. Price JR, Mitchell E, Tidy E, Hunot V. Cognitive behaviour therapy for chronic fatigue syndrome in adults. Cochrane Database Syst Rev 2008, (3):CD001027.
8. Prins JB, Bleijenberg G, Bazelmans E, Elving LD, de Boo TM, Severens JL, van der Wilt GJ, Spinhoven P, van der Meer JW. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet 2001, 357(9259):841-847. 10.1016/S0140-6736(00)04198-2, 11265953.
9. Stulemeijer M, de Jong LW, Fiselier TJ, Hoogveld SW, Bleijenberg G. Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: randomised controlled trial. BMJ 2005, 330(7481):14. 10.1136/bmj.38301.587106.63, 539840, 15585538.
10. Whiting P, Bagnall AM, Sowden AJ, Cornell JE, Mulrow CD, Ramirez G. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. JAMA 2001, 286(11):1360-1368. 10.1001/jama.286.11.1360, 11560542.
11. Brooks JC, Roberts N, Whitehouse G, Majeed T. Proton magnetic resonance spectroscopy and morphometry of the hippocampus in chronic fatigue syndrome. Br J Radiol 2000, 73(875):1206-1208.
12. Chaudhuri A, Condon BR, Gow JW, Brennan D, Hadley DM. Proton magnetic resonance spectroscopy of basal ganglia in chronic fatigue syndrome. Neuroreport 2003, 14(2):225-228. 10.1097/00001756-200302100-00013, 12598734.
13. de Lange FP, Kalkman JS, Bleijenberg G, Hagoort P, van der Meer JW, Toni I. Gray matter volume reduction in the chronic fatigue syndrome. Neuroimage 2005, 26(3):777-781. 10.1016/j.neuroimage.2005.02.037, 15955487.
14. de Lange FP, Koers A, Kalkman JS, Bleijenberg G, Hagoort P, van der Meer JW, Toni I. Increase in prefrontal cortical volume following cognitive behavioural therapy in patients with chronic fatigue syndrome. Brain 2008, 131(Pt 8):2172-2180.
15. Mathew SJ, Mao X, Keegan KA, Levine SM, Smith EL, Heier LA, Otcheretko V, Coplan JD, Shungu DC. Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T (1)H MRS imaging study. NMR Biomed 2009, 22(3):251-258. 10.1002/nbm.1315, 18942064.
16. Puri BK, Counsell SJ, Zaman R, Main J, Collins AG, Hajnal JV, Davey NJ. Relative increase in choline in the occipital cortex in chronic fatigue syndrome. Acta Psychiatr Scand 2002, 106(3):224-226. 10.1034/j.1600-0447.2002.01300.x, 12197861.
17. Tomoda A, Miike T, Yamada E, Honda H, Moroi T, Ogawa M, Ohtani Y, Morishita S. Chronic fatigue syndrome in childhood. Brain Dev 2000, 22(1):60-64. 10.1016/S0387-7604(99)00111-4, 10761837.
18. Schillings ML, Kalkman JS, van der Werf SP, van Engelen BG, Bleijenberg G, Zwarts MJ. Diminished central activation during maximal voluntary contraction in chronic fatigue syndrome. Clin Neurophysiol 2004, 115(11):2518-2524. 10.1016/j.clinph.2004.06.007, 15465441.
19. Ortega-Hernandez OD, Shoenfeld Y. Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence?. Ann N Y Acad Sci 2009, 1173:600-609. 10.1111/j.1749-6632.2009.04799.x, 19758205.
20. Nancy AL, Shoenfeld Y. Chronic fatigue syndrome with autoantibodies-the result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant. Autoimmun Rev 2008, 8(1):52-55. 10.1016/j.autrev.2008.07.026, 18725327.
21. Rosenblum H, Shoenfeld Y, Amital H. The common immunogenic etiology of chronic fatigue syndrome: from infections to vaccines via adjuvants to the ASIA syndrome. Infect Dis Clin North Am 2011, 25(4):851-863. 10.1016/j.idc.2011.07.012, 22054760.
22. Sleigh KM, Danforth DG, Hall RT, Fleming JA, Stiver HG. Double-blind, randomized study of the effects of influenza vaccination on the specific antibody response and clinical course of patients with chronic fatigue syndrome. Can J Infect Dis 2000, 11(5):267-273. 2094778, 18159300.
23. Taga K, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 1992, 148(4):1143-1148.
24. Levings MK, Sangregorio R, Roncarolo MG. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001, 193(11):1295-1302. 10.1084/jem.193.11.1295, 2193376, 11390436.
25. Coyle AJ, Gutierrez-Ramos JC. The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat Immunol 2001, 2(3):203-209. 10.1038/85251, 11224518.
26. Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008, 26:677-704. 10.1146/annurev.immunol.26.021607.090331, 18173375.
27. Watanabe N, Gavrieli M, Sedy JR, Yang J, Fallarino F, Loftin SK, Hurchla MA, Zimmerman N, Sim J, Zang X, et al. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol 2003, 4(7):670-679. 10.1038/ni944, 12796776.
28. Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res 2004, 56(2):157-170. 10.1016/S0022-3999(03)00371-4, 15016573.
29. Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994, 38(5):383-392. 10.1016/0022-3999(94)90099-X, 7965927.
30. Mulder SF, Jacobs JF, Olde Nordkamp MA, Galama JM, Desar IM, Torensma R, Teerenstra S, Mulders PF, Vissers KC, Punt CJ, et al. Cancer patients treated with sunitinib or sorafenib have sufficient antibody and cellular immune responses to warrant influenza vaccination. Clin Cancer Res 2011, 17(13):4541-4549. 10.1158/1078-0432.CCR-11-0253, 21712444.
31. de Jong JC, Palache AM, Beyer WE, Rimmelzwaan GF, Boon AC, Osterhaus AD. Haemagglutination-inhibiting antibody to influenza virus. Dev Biol (Basel) 2003, 115:63-73.
32. Pollyea DA, Brown JM, Horning SJ. Utility of influenza vaccination for oncology patients. J Clin Oncol 2010, 28(14):2481-2490. 10.1200/JCO.2009.26.6908, 20385981.